Stocks News

LAST PRICE
332.7100
TODAY'S CHANGE (%)
Trending Up7.1300 (2.1899%)

Bid / Lots
332.7100/ 1
Ask / Lots
333.7400/ 6
Open / Previous Close
324.3000 / 325.5800
Day Range
Low 321.6200
High 333.5050
52 Week Range
Low 262.1200
High 387.9900
Volume
93,371
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference, from 9:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  9:00AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  
  Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference
  HERCULES, Calif.--(BUSINESS WIRE)--November 21, 2024--
  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will host one-on-one meetings with analysts and investors during Citi's 2024 Global Healthcare Conference in Miami, FL, December 3-5, 2024.
Nov 18, 2024
- DJ Bio-Rad Laboratories On Track for Longest Losing Streak Since January 2022 -- Data Talk, from 11:05AM ET on Monday Nov 18, 2024 by Dow Jones
  11:05AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  
  Bio-Rad Laboratories, Inc. Class A (BIO) is currently at $310.39, down $9.92 or 3.1%
  
  --Would be lowest close since Aug. 22, 2024, when it closed at $310.03
Nov 15, 2024
- DJ Bio-Rad Laboratories Down Over 6%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk, from 12:13PM ET on Friday Nov 15, 2024 by Dow Jones
  12:13PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  
  Bio-Rad Laboratories, Inc. Class A (BIO) is currently at $328.30, down $21.93 or 6.26%
  
  --Would be lowest close since Oct. 25, 2024, when it closed at $320.23
Oct 31, 2024
- DJ Bio-Rad Laboratories Is Maintained at Buy by Citigroup, from 5:06PM ET on Thursday Oct 31, 2024 by Dow Jones
  5:06PM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BIO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 17:06 ET (21:06 GMT)
- DJ Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital, from 3:49PM ET on Thursday Oct 31, 2024 by Dow Jones
  3:49PM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: BIO, BIO.B
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BIO/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 31, 2024 15:49 ET (19:49 GMT)

Today
- DJ Masimo Price Target Raised to $190.00/Share From $170.00 by Stifel, from 4 hours ago by Dow Jones
  4 hours ago by Dow Jones
  Companies Mentioned: MASI
Nov 20, 2024
- Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference, from 4:30PM ET on Wednesday Nov 20, 2024 by PR Newswire
  4:30PM ET on Wednesday Nov 20, 2024 by PR Newswire
  Companies Mentioned: PEN
- Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference, from 4:30PM ET on Wednesday Nov 20, 2024 by Dow Jones
  4:30PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: PEN
- DJ Penumbra Is Maintained at Overweight by Piper Sandler, from 1:13PM ET on Wednesday Nov 20, 2024 by Dow Jones
  1:13PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: PEN
Nov 19, 2024
- Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference, from 6:30AM ET on Tuesday Nov 19, 2024 by Dow Jones
  6:30AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: TFX
Nov 14, 2024
- Masimo to Present in the Jefferies London Healthcare Conference, from 9:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  9:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: MASI
- DJ Repligen Initiated at Peer Perform by Wolfe Research, from 8:53AM ET on Thursday Nov 14, 2024 by Dow Jones
  8:53AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: RGEN
- Wolfe Research Initiates Repligen at Peer Perform, from 8:28AM ET on Thursday Nov 14, 2024 by MT Newswires
  8:28AM ET on Thursday Nov 14, 2024 by MT Newswires
  Companies Mentioned: RGEN
Nov 13, 2024
- UBS Adjusts Price Target on Repligen to $190 From $185, Keeps Buy Rating, from 12:13PM ET on Wednesday Nov 13, 2024 by MT Newswires
  12:13PM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: RGEN
- Masimo to Present in Stifel 2024 Healthcare Conference, from 9:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
  9:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: MASI

Bio Rad Laboratories Inc
NYSE:BIOUnited States

Search Criteria

Yesterday

Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference, from 9:00AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 18, 2024

DJ Bio-Rad Laboratories On Track for Longest Losing Streak Since January 2022 -- Data Talk, from 11:05AM ET on Monday Nov 18, 2024 by Dow Jones

Nov 15, 2024

DJ Bio-Rad Laboratories Down Over 6%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk, from 12:13PM ET on Friday Nov 15, 2024 by Dow Jones

Oct 31, 2024

DJ Bio-Rad Laboratories Is Maintained at Buy by Citigroup, from 5:06PM ET on Thursday Oct 31, 2024 by Dow Jones

DJ Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital, from 3:49PM ET on Thursday Oct 31, 2024 by Dow Jones

Peers Headlines

Today

DJ Masimo Price Target Raised to $190.00/Share From $170.00 by Stifel, from 4 hours ago by Dow Jones

Nov 20, 2024

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference, from 4:30PM ET on Wednesday Nov 20, 2024 by PR Newswire

Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference, from 4:30PM ET on Wednesday Nov 20, 2024 by Dow Jones

DJ Penumbra Is Maintained at Overweight by Piper Sandler, from 1:13PM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 19, 2024

Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference, from 6:30AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 14, 2024

Masimo to Present in the Jefferies London Healthcare Conference, from 9:00AM ET on Thursday Nov 14, 2024 by Dow Jones

DJ Repligen Initiated at Peer Perform by Wolfe Research, from 8:53AM ET on Thursday Nov 14, 2024 by Dow Jones

Wolfe Research Initiates Repligen at Peer Perform, from 8:28AM ET on Thursday Nov 14, 2024 by MT Newswires

Nov 13, 2024

UBS Adjusts Price Target on Repligen to $190 From $185, Keeps Buy Rating, from 12:13PM ET on Wednesday Nov 13, 2024 by MT Newswires

Masimo to Present in Stifel 2024 Healthcare Conference, from 9:00AM ET on Wednesday Nov 13, 2024 by Dow Jones